ATI RN
Quizlet Lifespan Considerations for Nursing Pharmacology with Rationals Questions
Question 1 of 5
Which of the following antiparkinsonism drugs is an anticholinergic agent?
Correct Answer: C
Rationale: In this question, the correct answer is C) Trihexyphenidyl. Trihexyphenidyl is an anticholinergic agent commonly used in the treatment of Parkinson's disease to help manage tremors and muscle stiffness by blocking the action of acetylcholine in the brain. A) Amantadine is not an anticholinergic agent. It works by increasing the release of dopamine and blocking its reuptake. B) Selegiline is a monoamine oxidase-B (MAO-B) inhibitor that helps increase dopamine levels in the brain. D) Bromocriptine is a dopamine agonist that works by directly stimulating dopamine receptors. Understanding the differences between these medications is crucial for nursing pharmacology practice. Knowing the specific mechanisms of action of each drug helps nurses make informed decisions when administering medications to patients with Parkinson's disease. It also highlights the importance of understanding the pharmacological properties of drugs to ensure safe and effective patient care.
Question 2 of 5
Which of the following mediators is found mainly in long descending pathways from the midbrain to the dorsal horn?
Correct Answer: B
Rationale: The correct answer is B) Dynorphin. Dynorphin is a type of endogenous opioid peptide that acts as a neurotransmitter in the central nervous system. It is mainly found in long descending pathways from the midbrain to the dorsal horn. These pathways are involved in pain modulation and transmission. A) Prostaglandin E is a lipid compound that is involved in inflammation and pain signaling but is not primarily found in the specific pathways described in the question. C) Enkephalin is another type of endogenous opioid peptide that is involved in pain modulation, but it is not mainly found in the long descending pathways described in the question. D) Glutamate is a primary excitatory neurotransmitter in the central nervous system but is not specific to the long descending pathways involved in pain modulation and transmission. Understanding the specific mediators involved in pain pathways is crucial for nursing pharmacology students as it helps them understand the mechanisms of pain modulation and the targets of various pain medications. This knowledge is essential for providing effective pain management for patients across the lifespan.
Question 3 of 5
Which of the following agents is a full antagonist of opioid receptors?
Correct Answer: C
Rationale: In the context of nursing pharmacology, understanding the mechanism of action of different medications is crucial for safe and effective patient care. In this scenario, the correct answer is C) Naloxone, as it is a full antagonist of opioid receptors. Naloxone is a pure opioid antagonist, meaning it competes with and displaces opioids from the receptors, effectively reversing the effects of opioids. It is commonly used in emergency situations to counteract opioid overdose and restore normal respiratory function by blocking the opioid receptors in the brain. Meperidine (A) is an opioid analgesic that acts as a partial agonist at opioid receptors and also has serotonergic effects. Buprenorphine (B) is a partial agonist-antagonist at opioid receptors, often used in medication-assisted treatment for opioid addiction. Butorphanol (D) is a mixed agonist-antagonist opioid, with agonist effects at kappa receptors and antagonist effects at mu receptors. Educationally, this question highlights the importance of differentiating between opioid agonists, partial agonists, antagonists, and mixed agonist-antagonists in pharmacology. Understanding these distinctions is essential for selecting the appropriate medication based on the desired therapeutic effect and potential adverse reactions. It also emphasizes the critical role of naloxone in managing opioid overdoses and underscores its significance in nursing practice.
Question 4 of 5
The relief produced by intravenous morphine in dyspnea from pulmonary edema is associated with reduced:
Correct Answer: D
Rationale: The correct answer is D) All of the above. Explanation: - Intravenous morphine is effective in relieving dyspnea from pulmonary edema because it acts centrally to decrease the perception of shortness of breath. - Morphine also helps reduce patient anxiety, which can exacerbate dyspnea and contribute to increased distress. - Additionally, morphine's effects on reducing cardiac preload (venous tone) and afterload (peripheral resistance) help alleviate the strain on the heart and improve overall hemodynamics in pulmonary edema. Why the other options are incorrect: - Option A, Perception of shortness of breath, is only one aspect of the relief provided by morphine, but the drug also addresses other factors contributing to dyspnea. - Option B, Patient anxiety, is indeed reduced by morphine, but this is not the sole mechanism of action for its effectiveness in dyspnea relief. - Option C, while partially correct in mentioning the effects on cardiac preload and afterload, does not encompass the full range of morphine's actions in alleviating dyspnea in pulmonary edema. Educational context: Understanding the pharmacological effects of morphine in managing dyspnea in pulmonary edema is crucial for nursing practice. Nurses must comprehend how morphine works to relieve symptoms and improve patient outcomes. By grasping the holistic impact of morphine on dyspnea, nurses can provide effective care and support to patients experiencing respiratory distress. This knowledge enhances nursing pharmacology competence and empowers nurses to make informed decisions in clinical settings.
Question 5 of 5
Select the non-narcotic drug, which is a paraaminophenol derivative:
Correct Answer: D
Rationale: In this question, the correct answer is D) Paracetamol. Paracetamol is a paraaminophenol derivative, making it the non-narcotic drug in the list. A) Analgin is a pyrazolone derivative, not a paraaminophenol derivative, so it is incorrect. B) Aspirin is an NSAID (Non-Steroidal Anti-Inflammatory Drug) and not a paraaminophenol derivative, making it incorrect. C) Baclofen is a muscle relaxant and not a paraaminophenol derivative, so it is also incorrect. Understanding the classification of drugs based on their chemical structure is crucial in pharmacology as it helps nurses and healthcare professionals make informed decisions regarding drug administration, dosage, and potential interactions. Knowing that paracetamol is a paraaminophenol derivative helps in understanding its mechanism of action, side effects, and contraindications. This knowledge is essential in providing safe and effective patient care.